Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 80

1.

Inhibitory effects of selected antiviral compounds on human hepatitis B virus DNA synthesis.

Yokota T, Mochizuki S, Konno K, Mori S, Shigeta S, De Clercq E.

Antimicrob Agents Chemother. 1991 Feb;35(2):394-7.

2.

Comparative activities of several nucleoside analogs against duck hepatitis B virus in vitro.

Yokota T, Konno K, Chonan E, Mochizuki S, Kojima K, Shigeta S, de Clercq E.

Antimicrob Agents Chemother. 1990 Jul;34(7):1326-30.

3.

Phosphonylmethoxyalkyl derivatives of purine as inhibitors of human hepatitis B virus DNA synthesis.

Yokota T, Mochizuki S, Konno K, Mori S, Shigeta S, De Clercq E.

Nucleic Acids Symp Ser. 1990;(22):17-8.

PMID:
2101900
4.

Inhibitory effects of acyclic nucleoside phosphonates on human hepatitis B virus and duck hepatitis B virus infections in tissue culture.

Heijtink RA, Kruining J, de Wilde GA, Balzarini J, de Clercq E, Schalm SW.

Antimicrob Agents Chemother. 1994 Sep;38(9):2180-2.

5.

An in vitro system for screening anti-hepatitis B virus drugs.

Ueda K, Tsurimoto T, Nagahata T, Chisaka O, Matsubara K.

Virology. 1989 Mar;169(1):213-6.

PMID:
2466368
6.

Inhibition of duck hepatitis B virus replication in vitro by 2',3'-dideoxy-3'-azidothymidine and related compounds.

Suzuki S, Lorne D, Tyrrell J, Saneyoshi M.

Acta Virol. 1991 Sep;35(5):430-7.

PMID:
1688076
7.

Inhibition of duck hepatitis B virus replication by 2',3'-dideoxy-3'-fluoroguanosine in vitro and in vivo.

Hafkemeyer P, Keppler-Hafkemeyer A, al Haya MA, von Janta-Lipinski M, Matthes E, Lehmann C, Offensperger WB, Offensperger S, Gerok W, Blum HE.

Antimicrob Agents Chemother. 1996 Mar;40(3):792-4.

8.

2',3'-dideoxy-beta-L-5-fluorocytidine inhibits duck hepatitis B virus reverse transcription and suppresses viral DNA synthesis in hepatocytes, both in vitro and in vivo.

Zoulim F, Dannaoui E, Borel C, Hantz O, Lin TS, Liu SH, Trépo C, Cheng YC.

Antimicrob Agents Chemother. 1996 Feb;40(2):448-53.

10.

In vitro antiviral activity of penciclovir, a novel purine nucleoside, against duck hepatitis B virus.

Shaw T, Amor P, Civitico G, Boyd M, Locarnini S.

Antimicrob Agents Chemother. 1994 Apr;38(4):719-23.

11.

Inhibition of human and duck hepatitis B virus by 2',3'-dideoxy-3'-fluoroguanosine in vitro.

Schröder I, Holmgren B, Oberg M, Löfgren B.

Antiviral Res. 1998 Jan;37(1):57-66.

PMID:
9497073
12.
13.

In vitro and in vivo comparison of the abilities of purine and pyrimidine 2',3'-dideoxynucleosides to inhibit duck hepadnavirus.

Lee B, Luo WX, Suzuki S, Robins MJ, Tyrrell DL.

Antimicrob Agents Chemother. 1989 Mar;33(3):336-9.

14.

Inhibitory effect of 9-(2-phosphonylmethoxyethyl)-adenine (PMEA) on human and duck hepatitis B virus infection.

Heijtink RA, De Wilde GA, Kruining J, Berk L, Balzarini J, De Clercq E, Holy A, Schalm SW.

Antiviral Res. 1993 Jun;21(2):141-53.

PMID:
8338351
17.

Inhibition of hepatitis B virus production by modified 2',3'-dideoxy-thymidine and 2',3'-dideoxy-5-methylcytidine derivatives. In vitro and in vivo studies.

Matthes E, von Janta-Lipinski M, Will H, Schröder HC, Merz H, Steffen R, Müller WE.

Biochem Pharmacol. 1992 Apr 1;43(7):1571-7.

PMID:
1314607
18.

Effects of pyrimidine and purine analog combinations in the duck hepatitis B virus infection model.

Seignères B, Martin P, Werle B, Schorr O, Jamard C, Rimsky L, Trépo C, Zoulim F.

Antimicrob Agents Chemother. 2003 Jun;47(6):1842-52.

19.

Effect of Oenanthe javanica flavone on human and duck hepatitis B virus infection.

Wang WN, Yang XB, Liu HZ, Huang ZM, Wu GX.

Acta Pharmacol Sin. 2005 May;26(5):587-92.

20.

Selective inhibition of the duck hepatitis B virus by a new class of tetraazamacrocycles.

Hantz O, Borel C, Trabaud C, Zoulim F, Dessolin J, Camplo M, Vlieghe P, Bouygues M, Trepo C, Kraus JL.

Antimicrob Agents Chemother. 1997 Nov;41(11):2579-81.

Supplemental Content

Support Center